Filing Details

Accession Number:
0000784199-15-000169
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-01 16:35:37
Reporting Period:
2015-11-27
Filing Date:
2015-12-01
Accepted Time:
2015-12-01 16:35:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
784199 Cryolife Inc CRY Surgical & Medical Instruments & Apparatus (3841) 592417093
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1112830 Ashley David Lee Cryolife, Inc.
1655 Roberts Blvd, Nw
Kennesaw GA 30144
Executive Vp, Coo & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-27 10,581 $4.83 250,550 No 4 M Direct
Common Stock Disposition 2015-11-27 10,581 $11.03 239,969 No 4 S Direct
Common Stock Acquisiton 2015-11-30 1,219 $4.83 241,188 No 4 M Direct
Common Stock Disposition 2015-11-30 1,219 $11.03 239,969 No 4 S Direct
Common Stock Acquisiton 2015-11-30 4,000 $4.83 243,969 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-11-27 10,581 $0.00 10,581 $4.83
Common Stock Stock Option (Right to Buy) Disposition 2015-11-30 1,219 $0.00 1,219 $4.83
Common Stock Stock Option (Right to Buy) Disposition 2015-11-30 4,000 $0.00 4,000 $4.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,419 2010-02-23 2016-02-23 No 4 M Direct
13,200 2010-02-23 2016-02-23 No 4 M Direct
8,500 2010-02-23 2016-02-23 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,000 Indirect By Spouse
Common Stock 1,500 Indirect By Children
Footnotes
  1. The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 16, 2015.
  2. Reflects weighted average price. Range of prices was between $11.00 to $11.08. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  3. Reflects weighted average price. Range of prices was between $11.00 to $11.05. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  4. Stock option vested 33 1/3% per year beginning on the first anniversary of the grant date (February 23, 2009).